1. Home
  2. KRRO vs PFL Comparison

KRRO vs PFL Comparison

Compare KRRO & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • PFL
  • Stock Information
  • Founded
  • KRRO 2014
  • PFL 2003
  • Country
  • KRRO United States
  • PFL United States
  • Employees
  • KRRO N/A
  • PFL N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • PFL Finance Companies
  • Sector
  • KRRO Health Care
  • PFL Finance
  • Exchange
  • KRRO Nasdaq
  • PFL Nasdaq
  • Market Cap
  • KRRO 281.2M
  • PFL 329.9M
  • IPO Year
  • KRRO 2019
  • PFL N/A
  • Fundamental
  • Price
  • KRRO $26.29
  • PFL $8.48
  • Analyst Decision
  • KRRO Strong Buy
  • PFL
  • Analyst Count
  • KRRO 7
  • PFL 0
  • Target Price
  • KRRO $133.83
  • PFL N/A
  • AVG Volume (30 Days)
  • KRRO 61.9K
  • PFL 113.7K
  • Earning Date
  • KRRO 03-25-2025
  • PFL 01-01-0001
  • Dividend Yield
  • KRRO N/A
  • PFL 11.53%
  • EPS Growth
  • KRRO N/A
  • PFL N/A
  • EPS
  • KRRO N/A
  • PFL N/A
  • Revenue
  • KRRO N/A
  • PFL N/A
  • Revenue This Year
  • KRRO N/A
  • PFL N/A
  • Revenue Next Year
  • KRRO N/A
  • PFL N/A
  • P/E Ratio
  • KRRO N/A
  • PFL N/A
  • Revenue Growth
  • KRRO N/A
  • PFL N/A
  • 52 Week Low
  • KRRO $26.23
  • PFL $6.98
  • 52 Week High
  • KRRO $98.00
  • PFL $8.62
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 29.17
  • PFL 48.84
  • Support Level
  • KRRO $28.90
  • PFL $8.45
  • Resistance Level
  • KRRO $40.68
  • PFL $8.60
  • Average True Range (ATR)
  • KRRO 2.26
  • PFL 0.05
  • MACD
  • KRRO -0.36
  • PFL -0.00
  • Stochastic Oscillator
  • KRRO 0.42
  • PFL 34.21

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest

PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.

Share on Social Networks: